ZA200108733B - Substituted bicyclic herocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents. - Google Patents
Substituted bicyclic herocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents. Download PDFInfo
- Publication number
- ZA200108733B ZA200108733B ZA200108733A ZA200108733A ZA200108733B ZA 200108733 B ZA200108733 B ZA 200108733B ZA 200108733 A ZA200108733 A ZA 200108733A ZA 200108733 A ZA200108733 A ZA 200108733A ZA 200108733 B ZA200108733 B ZA 200108733B
- Authority
- ZA
- South Africa
- Prior art keywords
- dihydro
- phenyl
- ethoxy
- substituted
- benzoxazin
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 13
- 230000003579 anti-obesity Effects 0.000 title 1
- 239000000883 anti-obesity agent Substances 0.000 title 1
- 239000003529 anticholesteremic agent Substances 0.000 title 1
- 125000002619 bicyclic group Chemical group 0.000 title 1
- -1 cyano, formyl Chemical group 0.000 claims 207
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 168
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 165
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 112
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims 112
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims 112
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 claims 112
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 112
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 claims 112
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 claims 112
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 claims 111
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 111
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims 110
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims 110
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims 110
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 claims 108
- 150000001875 compounds Chemical class 0.000 claims 79
- 150000003839 salts Chemical class 0.000 claims 70
- 125000000217 alkyl group Chemical group 0.000 claims 66
- 125000003710 aryl alkyl group Chemical group 0.000 claims 65
- 125000003118 aryl group Chemical group 0.000 claims 61
- 229910052739 hydrogen Inorganic materials 0.000 claims 60
- 239000001257 hydrogen Substances 0.000 claims 60
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 claims 59
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 58
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 claims 57
- QMXOFBXZEKTJIK-UHFFFAOYSA-N Glycinol Natural products C1=C(O)C=C2OCC3(O)C4=CC=C(O)C=C4OC3C2=C1 QMXOFBXZEKTJIK-UHFFFAOYSA-N 0.000 claims 57
- HMBHAQMOBKLWRX-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine-3-carboxylic acid Chemical compound C1=CC=C2OC(C(=O)O)COC2=C1 HMBHAQMOBKLWRX-UHFFFAOYSA-N 0.000 claims 56
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims 56
- BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 claims 56
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 claims 56
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 56
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 claims 56
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 claims 56
- 239000004471 Glycine Substances 0.000 claims 56
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 56
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 56
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 56
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 56
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 claims 56
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 56
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 56
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 56
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 56
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 claims 56
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 claims 56
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 claims 56
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 56
- 235000004279 alanine Nutrition 0.000 claims 56
- 150000003927 aminopyridines Chemical class 0.000 claims 56
- 150000005005 aminopyrimidines Chemical class 0.000 claims 56
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims 56
- 229960003237 betaine Drugs 0.000 claims 56
- 229960001948 caffeine Drugs 0.000 claims 56
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 56
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims 56
- 229960001231 choline Drugs 0.000 claims 56
- 229940075419 choline hydroxide Drugs 0.000 claims 56
- 229910052802 copper Inorganic materials 0.000 claims 56
- 125000005265 dialkylamine group Chemical group 0.000 claims 56
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 claims 56
- 229960002442 glucosamine Drugs 0.000 claims 56
- XGIHQYAWBCFNPY-AZOCGYLKSA-N hydrabamine Chemical compound C([C@@H]12)CC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC[C@@]1(C)CNCCNC[C@@]1(C)[C@@H]2CCC3=CC(C(C)C)=CC=C3[C@@]2(C)CCC1 XGIHQYAWBCFNPY-AZOCGYLKSA-N 0.000 claims 56
- 229910052742 iron Inorganic materials 0.000 claims 56
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 56
- 229960000310 isoleucine Drugs 0.000 claims 56
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 claims 56
- 229910052749 magnesium Inorganic materials 0.000 claims 56
- 229910052748 manganese Inorganic materials 0.000 claims 56
- 229960003194 meglumine Drugs 0.000 claims 56
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 claims 56
- 229960004919 procaine Drugs 0.000 claims 56
- 229940063673 spermidine Drugs 0.000 claims 56
- 229960004559 theobromine Drugs 0.000 claims 56
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 claims 56
- 235000019157 thiamine Nutrition 0.000 claims 56
- 229960003495 thiamine Drugs 0.000 claims 56
- 239000011721 thiamine Substances 0.000 claims 56
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 claims 56
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 56
- 229960000281 trometamol Drugs 0.000 claims 56
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 56
- 239000004474 valine Substances 0.000 claims 56
- 229910052725 zinc Inorganic materials 0.000 claims 56
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 55
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical class [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 55
- 239000004475 Arginine Substances 0.000 claims 55
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims 55
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims 55
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 55
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 55
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 55
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 55
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 55
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 55
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 55
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 55
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 55
- 239000004472 Lysine Substances 0.000 claims 55
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 55
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 55
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 55
- 239000004473 Threonine Substances 0.000 claims 55
- 150000003863 ammonium salts Chemical class 0.000 claims 55
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 55
- 229910052791 calcium Inorganic materials 0.000 claims 55
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 55
- 235000018417 cysteine Nutrition 0.000 claims 55
- 229960003067 cystine Drugs 0.000 claims 55
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims 55
- 150000002357 guanidines Chemical class 0.000 claims 55
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 55
- 229960002591 hydroxyproline Drugs 0.000 claims 55
- 229930182817 methionine Natural products 0.000 claims 55
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 55
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims 55
- MWGATWIBSKHFMR-UHFFFAOYSA-N 2-anilinoethanol Chemical compound OCCNC1=CC=CC=C1 MWGATWIBSKHFMR-UHFFFAOYSA-N 0.000 claims 54
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 54
- 229940043237 diethanolamine Drugs 0.000 claims 54
- WNYIBZHOMJZDKN-UHFFFAOYSA-N n-(2-acetamidoethyl)acetamide Chemical compound CC(=O)NCCNC(C)=O WNYIBZHOMJZDKN-UHFFFAOYSA-N 0.000 claims 54
- 150000003212 purines Chemical class 0.000 claims 54
- 229940013085 2-diethylaminoethanol Drugs 0.000 claims 53
- UPABQMWFWCMOFV-UHFFFAOYSA-N benethamine Chemical compound C=1C=CC=CC=1CNCCC1=CC=CC=C1 UPABQMWFWCMOFV-UHFFFAOYSA-N 0.000 claims 53
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 claims 53
- 229940012017 ethylenediamine Drugs 0.000 claims 53
- 229910052700 potassium Inorganic materials 0.000 claims 53
- 125000000623 heterocyclic group Chemical group 0.000 claims 52
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 52
- 125000005270 trialkylamine group Chemical group 0.000 claims 52
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims 51
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims 51
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims 51
- 229960003104 ornithine Drugs 0.000 claims 51
- 125000000753 cycloalkyl group Chemical group 0.000 claims 49
- NOUUUQMKVOUUNR-UHFFFAOYSA-N n,n'-diphenylethane-1,2-diamine Chemical compound C=1C=CC=CC=1NCCNC1=CC=CC=C1 NOUUUQMKVOUUNR-UHFFFAOYSA-N 0.000 claims 49
- 125000002252 acyl group Chemical group 0.000 claims 48
- 125000004475 heteroaralkyl group Chemical group 0.000 claims 43
- 125000001072 heteroaryl group Chemical group 0.000 claims 43
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 41
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 39
- 125000003545 alkoxy group Chemical group 0.000 claims 33
- 125000004432 carbon atom Chemical group C* 0.000 claims 31
- 229910052757 nitrogen Inorganic materials 0.000 claims 30
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 29
- 229910052799 carbon Inorganic materials 0.000 claims 28
- 150000002431 hydrogen Chemical class 0.000 claims 27
- 229910052736 halogen Inorganic materials 0.000 claims 24
- 150000002367 halogens Chemical class 0.000 claims 24
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 24
- 125000004423 acyloxy group Chemical group 0.000 claims 21
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 21
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 21
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 21
- 125000004442 acylamino group Chemical group 0.000 claims 20
- 125000004414 alkyl thio group Chemical group 0.000 claims 20
- 125000001769 aryl amino group Chemical group 0.000 claims 20
- 125000004104 aryloxy group Chemical group 0.000 claims 20
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 20
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 20
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 19
- 229910052760 oxygen Inorganic materials 0.000 claims 19
- 125000001691 aryl alkyl amino group Chemical group 0.000 claims 18
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 18
- 125000004663 dialkyl amino group Chemical group 0.000 claims 18
- 125000005553 heteroaryloxy group Chemical group 0.000 claims 18
- 239000001301 oxygen Substances 0.000 claims 18
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 12
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 12
- 125000005100 aryl amino carbonyl group Chemical group 0.000 claims 12
- 125000005842 heteroatom Chemical group 0.000 claims 12
- 229910052717 sulfur Inorganic materials 0.000 claims 12
- 239000011593 sulfur Chemical group 0.000 claims 12
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 11
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 11
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 10
- 239000012453 solvate Substances 0.000 claims 10
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 claims 9
- 125000005162 aryl oxy carbonyl amino group Chemical group 0.000 claims 9
- 125000005647 linker group Chemical group 0.000 claims 9
- 125000004043 oxo group Chemical group O=* 0.000 claims 9
- 150000003458 sulfonic acid derivatives Chemical class 0.000 claims 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 8
- MHMMGRGOOBJCSR-UHFFFAOYSA-N 2-[[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]methyl]-2-ethoxy-3-(2-fluorophenyl)propanoic acid Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1CC(OCC)(C(O)=O)CC1=CC=CC=C1F MHMMGRGOOBJCSR-UHFFFAOYSA-N 0.000 claims 5
- YPCXMZHWVUITBA-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid Chemical compound C=1C=C(OCCN2C3=CC=CC=C3SCC2)C=CC=1CC(C(=O)O)OC1=CC=CC=C1 YPCXMZHWVUITBA-UHFFFAOYSA-N 0.000 claims 5
- KRNNZPFAPLHPNP-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-phenoxypropanoic acid Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1CC(C(=O)O)OC1=CC=CC=C1 KRNNZPFAPLHPNP-UHFFFAOYSA-N 0.000 claims 5
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 5
- GKBWKSJWXJMEEQ-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCCN1C2=CC=CC=C2SCC1 GKBWKSJWXJMEEQ-UHFFFAOYSA-N 0.000 claims 4
- WQBNZXVSFXLTGV-UHFFFAOYSA-N 3-[6-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]naphthalen-1-yl]-2-ethoxypropanoic acid Chemical compound C1COC2=CC=CC=C2N1CCOC1=CC=C2C(CC(OCC)C(O)=O)=CC=CC2=C1 WQBNZXVSFXLTGV-UHFFFAOYSA-N 0.000 claims 4
- ATTHDPUAOALIJO-PLRJNAJWSA-N ethyl (Z)-3-[6-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]naphthalen-1-yl]-2-ethoxyprop-2-enoate Chemical compound C1CSC2=CC=CC=C2N1CCOC1=CC=C2C(/C=C(\OCC)C(=O)OCC)=CC=CC2=C1 ATTHDPUAOALIJO-PLRJNAJWSA-N 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000001624 naphthyl group Chemical group 0.000 claims 4
- 125000000547 substituted alkyl group Chemical group 0.000 claims 4
- VUMWEERYGJRFPZ-UHFFFAOYSA-N 3-[2-(2,3-dihydro-1,4-benzothiazin-4-ylmethyl)-1-benzofuran-5-yl]-2-ethoxypropanoic acid Chemical compound C1CSC2=CC=CC=C2N1CC1=CC2=CC(CC(OCC)C(O)=O)=CC=C2O1 VUMWEERYGJRFPZ-UHFFFAOYSA-N 0.000 claims 3
- XTADJISLWFZGIO-UHFFFAOYSA-N 3-[4-[(4-benzyl-2,3-dihydro-1,4-benzoxazin-2-yl)methoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCC1OC2=CC=CC=C2N(CC=2C=CC=CC=2)C1 XTADJISLWFZGIO-UHFFFAOYSA-N 0.000 claims 3
- ODYZDBJNDOGJKT-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-methyl-2-phenoxypropanoic acid Chemical compound C=1C=C(OCCN2C3=CC=CC=C3SCC2)C=CC=1CC(C)(C(O)=O)OC1=CC=CC=C1 ODYZDBJNDOGJKT-UHFFFAOYSA-N 0.000 claims 3
- NPIGSANZDQELNH-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-ethoxy-2-methylpropanoic acid Chemical compound C1=CC(CC(C)(OCC)C(O)=O)=CC=C1OCCN1C2=CC=CC=C2OCC1 NPIGSANZDQELNH-UHFFFAOYSA-N 0.000 claims 3
- BDCDPHXWHMTYJB-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-ethoxypropanamide Chemical compound C1=CC(CC(OCC)C(N)=O)=CC=C1OCCN1C2=CC=CC=C2OCC1 BDCDPHXWHMTYJB-UHFFFAOYSA-N 0.000 claims 3
- KCOTUBYAAREJGC-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-methyl-2-phenoxypropanoic acid Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1CC(C)(C(O)=O)OC1=CC=CC=C1 KCOTUBYAAREJGC-UHFFFAOYSA-N 0.000 claims 3
- BAOZZIMJVLTJIQ-UHFFFAOYSA-N 3-[6-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]naphthalen-1-yl]-2-ethoxypropanoic acid Chemical compound C1CSC2=CC=CC=C2N1CCOC1=CC=C2C(CC(OCC)C(O)=O)=CC=CC2=C1 BAOZZIMJVLTJIQ-UHFFFAOYSA-N 0.000 claims 3
- 239000002253 acid Substances 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- RJRKOQPJMZOZAQ-UHFFFAOYSA-N 2-butoxy-3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]propanoic acid Chemical compound C1=CC(CC(OCCCC)C(O)=O)=CC=C1OCCN1C2=CC=CC=C2OCC1 RJRKOQPJMZOZAQ-UHFFFAOYSA-N 0.000 claims 2
- DQDCKBWSBKGOQH-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-ethoxypropanamide Chemical compound C1=CC(CC(OCC)C(N)=O)=CC=C1OCCN1C2=CC=CC=C2SCC1 DQDCKBWSBKGOQH-UHFFFAOYSA-N 0.000 claims 2
- XSSLBZJZTWIQPZ-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-hydroxypropanoic acid Chemical compound C1=CC(CC(O)C(O)=O)=CC=C1OCCN1C2=CC=CC=C2SCC1 XSSLBZJZTWIQPZ-UHFFFAOYSA-N 0.000 claims 2
- BSDNCIHDROVWCO-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-ethoxy-n-methylpropanamide Chemical compound C1=CC(CC(OCC)C(=O)NC)=CC=C1OCCN1C2=CC=CC=C2OCC1 BSDNCIHDROVWCO-UHFFFAOYSA-N 0.000 claims 2
- GGAOXTIHFIYDPC-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-ethoxypropanoic acid Chemical compound C1=CC(CC(OCC)C(O)=O)=CC=C1OCCN1C2=CC=CC=C2OCC1 GGAOXTIHFIYDPC-UHFFFAOYSA-N 0.000 claims 2
- BFLZHLOGOOYEAN-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-hexoxypropanoic acid Chemical compound C1=CC(CC(OCCCCCC)C(O)=O)=CC=C1OCCN1C2=CC=CC=C2OCC1 BFLZHLOGOOYEAN-UHFFFAOYSA-N 0.000 claims 2
- UVYZEYXMOFYLQT-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-hydroxypropanoic acid Chemical class C1=CC(CC(O)C(O)=O)=CC=C1OCCN1C2=CC=CC=C2OCC1 UVYZEYXMOFYLQT-UHFFFAOYSA-N 0.000 claims 2
- LVGVAOOYUUFWNS-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-phenylmethoxypropanoic acid Chemical class C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1CC(C(=O)O)OCC1=CC=CC=C1 LVGVAOOYUUFWNS-UHFFFAOYSA-N 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000004103 aminoalkyl group Chemical group 0.000 claims 2
- 125000005160 aryl oxy alkyl group Chemical group 0.000 claims 2
- IKCYLYMMVOWCGZ-UHFFFAOYSA-N ethyl 3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-hydroxypropanoate Chemical compound C1=CC(CC(O)C(=O)OCC)=CC=C1OCCN1C2=CC=CC=C2SCC1 IKCYLYMMVOWCGZ-UHFFFAOYSA-N 0.000 claims 2
- ZOVHBEKKCBZCRQ-UHFFFAOYSA-N methyl 2-ethoxy-3-[4-[(4-methyl-2,3-dihydro-1,4-benzoxazin-2-yl)methoxy]phenyl]propanoate Chemical compound C1=CC(CC(OCC)C(=O)OC)=CC=C1OCC1OC2=CC=CC=C2N(C)C1 ZOVHBEKKCBZCRQ-UHFFFAOYSA-N 0.000 claims 2
- UNILYMLSNCMOMF-UHFFFAOYSA-N methyl 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-phenoxypropanoate Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1CC(C(=O)OC)OC1=CC=CC=C1 UNILYMLSNCMOMF-UHFFFAOYSA-N 0.000 claims 2
- PBZSAMQPGQTMLD-UHFFFAOYSA-N methyl 3-[6-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]naphthalen-1-yl]-2-ethoxypropanoate Chemical compound C1CSC2=CC=CC=C2N1CCOC1=CC=C2C(CC(OCC)C(=O)OC)=CC=CC2=C1 PBZSAMQPGQTMLD-UHFFFAOYSA-N 0.000 claims 2
- ACTNHJDHMQSOGL-UHFFFAOYSA-N n',n'-dibenzylethane-1,2-diamine Chemical compound C=1C=CC=CC=1CN(CCN)CC1=CC=CC=C1 ACTNHJDHMQSOGL-UHFFFAOYSA-N 0.000 claims 2
- QPMYZKIUFGMGKK-UHFFFAOYSA-N (4-nitrophenyl) 3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-ethoxypropanoate Chemical compound C=1C=C(OCCN2C3=CC=CC=C3SCC2)C=CC=1CC(OCC)C(=O)OC1=CC=C([N+]([O-])=O)C=C1 QPMYZKIUFGMGKK-UHFFFAOYSA-N 0.000 claims 1
- GRWKNBPOGBTZMN-UHFFFAOYSA-N 2-benzyl-3-phenylpropane-1,2-diamine Chemical compound C=1C=CC=CC=1CC(N)(CN)CC1=CC=CC=C1 GRWKNBPOGBTZMN-UHFFFAOYSA-N 0.000 claims 1
- ROHGIKOWUPXUPJ-UHFFFAOYSA-N 3-[4-[(4-benzyl-2,3-dihydro-1,4-benzoxazin-2-yl)methoxy]phenyl]-2-ethoxy-2-(4-nitrophenyl)propanoic acid Chemical compound C=1C=C([N+]([O-])=O)C=CC=1C(OCC)(C(O)=O)CC(C=C1)=CC=C1OCC(OC1=CC=CC=C11)CN1CC1=CC=CC=C1 ROHGIKOWUPXUPJ-UHFFFAOYSA-N 0.000 claims 1
- BTNSRAJLQDPUHB-UHFFFAOYSA-N 3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-ethoxy-n-methylpropanamide Chemical compound C1=CC(CC(OCC)C(=O)NC)=CC=C1OCCN1C2=CC=CC=C2SCC1 BTNSRAJLQDPUHB-UHFFFAOYSA-N 0.000 claims 1
- 108010052300 RA X peptide Proteins 0.000 claims 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims 1
- 229910052782 aluminium Chemical class 0.000 claims 1
- 150000001412 amines Chemical class 0.000 claims 1
- 125000003277 amino group Chemical group 0.000 claims 1
- 150000008064 anhydrides Chemical group 0.000 claims 1
- 125000005334 azaindolyl group Chemical group N1N=C(C2=CC=CC=C12)* 0.000 claims 1
- 125000004618 benzofuryl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004619 benzopyranyl group Chemical group O1C(C=CC2=C1C=CC=C2)* 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000018044 dehydration Effects 0.000 claims 1
- 238000006297 dehydration reaction Methods 0.000 claims 1
- 125000004598 dihydrobenzofuryl group Chemical group O1C(CC2=C1C=CC=C2)* 0.000 claims 1
- 125000004586 dihydrobenzopyranyl group Chemical group O1C(CCC2=C1C=CC=C2)* 0.000 claims 1
- 238000005906 dihydroxylation reaction Methods 0.000 claims 1
- PONXTPCRRASWKW-KBPBESRZSA-N diphenylethylenediamine Chemical compound C1([C@H](N)[C@@H](N)C=2C=CC=CC=2)=CC=CC=C1 PONXTPCRRASWKW-KBPBESRZSA-N 0.000 claims 1
- CINHGPHCEQNNKA-HEHNFIMWSA-N ethyl (E)-3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-ethoxyprop-2-enoate Chemical compound C1=CC(\C=C(\OCC)C(=O)OCC)=CC=C1OCCN1C2=CC=CC=C2SCC1 CINHGPHCEQNNKA-HEHNFIMWSA-N 0.000 claims 1
- FDBUMAZMKYPOHP-LHLOQNFPSA-N ethyl (E)-3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-phenoxyprop-2-enoate Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1\C=C(C(=O)OCC)\OC1=CC=CC=C1 FDBUMAZMKYPOHP-LHLOQNFPSA-N 0.000 claims 1
- ATTHDPUAOALIJO-NCELDCMTSA-N ethyl (E)-3-[6-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]naphthalen-1-yl]-2-ethoxyprop-2-enoate Chemical compound C1CSC2=CC=CC=C2N1CCOC1=CC=C2C(\C=C(\OCC)C(=O)OCC)=CC=CC2=C1 ATTHDPUAOALIJO-NCELDCMTSA-N 0.000 claims 1
- CBJLDOAEMVGSDO-OEAKJJBVSA-N ethyl (e)-3-[2-(2,3-dihydro-1,4-benzoxazin-4-ylmethyl)-1-benzofuran-5-yl]-2-ethoxyprop-2-enoate Chemical compound C1COC2=CC=CC=C2N1CC1=CC2=CC(\C=C(\OCC)C(=O)OCC)=CC=C2O1 CBJLDOAEMVGSDO-OEAKJJBVSA-N 0.000 claims 1
- FOGZPJPPKVOAEG-QQTULTPQSA-N ethyl (z)-3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-phenoxyprop-2-enoate Chemical compound C=1C=C(OCCN2C3=CC=CC=C3SCC2)C=CC=1/C=C(C(=O)OCC)\OC1=CC=CC=C1 FOGZPJPPKVOAEG-QQTULTPQSA-N 0.000 claims 1
- OPYWHBQNRJKQBY-XLNRJJMWSA-N ethyl (z)-3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-ethoxyprop-2-enoate Chemical compound C1=CC(/C=C(\OCC)C(=O)OCC)=CC=C1OCCN1C2=CC=CC=C2OCC1 OPYWHBQNRJKQBY-XLNRJJMWSA-N 0.000 claims 1
- FDBUMAZMKYPOHP-QOMWVZHYSA-N ethyl (z)-3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-phenoxyprop-2-enoate Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1/C=C(C(=O)OCC)\OC1=CC=CC=C1 FDBUMAZMKYPOHP-QOMWVZHYSA-N 0.000 claims 1
- CKYQFZCHIWADPF-UHFFFAOYSA-N ethyl 2-butoxy-3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]propanoate Chemical compound C1=CC(CC(OCCCC)C(=O)OCC)=CC=C1OCCN1C2=CC=CC=C2OCC1 CKYQFZCHIWADPF-UHFFFAOYSA-N 0.000 claims 1
- PQXCSWWRPIMVIP-UHFFFAOYSA-N ethyl 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-hexoxypropanoate Chemical compound C1=CC(CC(OCCCCCC)C(=O)OCC)=CC=C1OCCN1C2=CC=CC=C2OCC1 PQXCSWWRPIMVIP-UHFFFAOYSA-N 0.000 claims 1
- PEBWFGOQVARCHJ-UHFFFAOYSA-N ethyl 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-hydroxypropanoate Chemical compound C1=CC(CC(O)C(=O)OCC)=CC=C1OCCN1C2=CC=CC=C2OCC1 PEBWFGOQVARCHJ-UHFFFAOYSA-N 0.000 claims 1
- FJVZJKKVARYFMD-UHFFFAOYSA-N ethyl 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-phenylmethoxypropanoate Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1CC(C(=O)OCC)OCC1=CC=CC=C1 FJVZJKKVARYFMD-UHFFFAOYSA-N 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 125000003387 indolinyl group Chemical group N1(CCC2=CC=CC=C12)* 0.000 claims 1
- 125000001041 indolyl group Chemical group 0.000 claims 1
- MNQXEPWTCARIMG-UHFFFAOYSA-N methyl 2-[[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]methyl]-2-ethoxy-3-(2-fluorophenyl)propanoate Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1CC(OCC)(C(=O)OC)CC1=CC=CC=C1F MNQXEPWTCARIMG-UHFFFAOYSA-N 0.000 claims 1
- XFECTTWJODDBNV-UHFFFAOYSA-N methyl 3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-ethoxypropanoate Chemical compound C1=CC(CC(OCC)C(=O)OC)=CC=C1OCCN1C2=CC=CC=C2OCC1 XFECTTWJODDBNV-UHFFFAOYSA-N 0.000 claims 1
- GGPUBHNWQRASQZ-UHFFFAOYSA-N n-benzyl-3-[4-[2-(2,3-dihydro-1,4-benzothiazin-4-yl)ethoxy]phenyl]-2-ethoxypropanamide Chemical compound C=1C=C(OCCN2C3=CC=CC=C3SCC2)C=CC=1CC(OCC)C(=O)NCC1=CC=CC=C1 GGPUBHNWQRASQZ-UHFFFAOYSA-N 0.000 claims 1
- ITTKNPXOMGJVDP-UHFFFAOYSA-N n-benzyl-3-[4-[2-(2,3-dihydro-1,4-benzoxazin-4-yl)ethoxy]phenyl]-2-ethoxypropanamide Chemical compound C=1C=C(OCCN2C3=CC=CC=C3OCC2)C=CC=1CC(OCC)C(=O)NCC1=CC=CC=C1 ITTKNPXOMGJVDP-UHFFFAOYSA-N 0.000 claims 1
- 125000004957 naphthylene group Chemical group 0.000 claims 1
- 125000004430 oxygen atom Chemical group O* 0.000 claims 1
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 claims 1
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims 1
- 125000003226 pyrazolyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000004001 thioalkyl group Chemical group 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Neurosurgery (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Child & Adolescent Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN484MA1999 | 1999-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200108733B true ZA200108733B (en) | 2003-01-23 |
Family
ID=11095336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200108733A ZA200108733B (en) | 1999-04-28 | 2001-10-23 | Substituted bicyclic herocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents. |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7348426B1 (no) |
| EP (1) | EP1175412A1 (no) |
| JP (1) | JP2002543194A (no) |
| KR (1) | KR100610578B1 (no) |
| CN (1) | CN1353699A (no) |
| AU (1) | AU781079B2 (no) |
| BG (1) | BG106146A (no) |
| BR (1) | BR0010139A (no) |
| CA (1) | CA2371757A1 (no) |
| CZ (1) | CZ20013832A3 (no) |
| EE (1) | EE200100540A (no) |
| HR (1) | HRP20010785A2 (no) |
| HU (1) | HUP0600105A3 (no) |
| IL (1) | IL146104A0 (no) |
| MX (1) | MXPA01010916A (no) |
| NO (1) | NO320805B1 (no) |
| NZ (1) | NZ515284A (no) |
| PL (1) | PL351987A1 (no) |
| RU (1) | RU2278114C2 (no) |
| SK (1) | SK15092001A3 (no) |
| TR (1) | TR200103848T2 (no) |
| UA (1) | UA73501C2 (no) |
| WO (1) | WO2000066572A1 (no) |
| YU (1) | YU75101A (no) |
| ZA (1) | ZA200108733B (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002212672A1 (en) * | 2000-10-12 | 2002-04-22 | Dr. Reddy's Research Foundation | Salts of benzothiazine and benzoxazine derivatives and pharmaceutical compositions containing them |
| DE60210784T2 (de) * | 2001-08-29 | 2006-11-02 | Warner-Lambert Co. Llc | Orale antidiabetische wirkstoffe |
| WO2003024944A1 (en) * | 2001-09-20 | 2003-03-27 | Dr. Reddy's Laboratories Ltd. | An improved process for the preparation of bicyclic antidiabetic compounds |
| WO2003027084A1 (en) * | 2001-09-25 | 2003-04-03 | Dr. Reddy's Laboratories Ltd. | Improved process for the preparation of optically active phenoxazine derivatives as antidiabetic agents |
| WO2003033456A1 (en) | 2001-10-16 | 2003-04-24 | Dr. Reddy's Laboratories Ltd. | NOVEL β-PHENYL-α-OXYSUBSTITUTED PROPIONIC DERIVATIVES: PROCESS FOR ITS PREPARATION AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALLY IMPORTANT COMPOUNDS |
| AU2003244514A1 (en) * | 2002-02-07 | 2003-09-02 | Dr. Reddy's Laboratories Limited | Novel polymorphic forms of bicyclic antidiabetic agents: process for their preparation and pharmaceutical compositions containing them |
| US6716842B2 (en) | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
| ATE384699T1 (de) * | 2002-04-30 | 2008-02-15 | Ucb Pharma Sa | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten |
| WO2003099800A1 (en) * | 2002-05-23 | 2003-12-04 | Dr. Reddy's Laboratories Limited | An improved process for the preparation of bicyclic antidiabetic agents |
| MXPA05004743A (es) | 2002-11-08 | 2005-08-03 | Hoffmann La Roche | Derivados 4-alcoxioxazol sustituidos como agonistas ppar. |
| US7262303B2 (en) | 2003-09-29 | 2007-08-28 | Hoffman-La Roche Inc. | Process for the production of chiral propionic acid derivatives |
| DE202004002953U1 (de) * | 2004-02-26 | 2004-04-29 | Winkler, Wilhelm | Verbindungseinheit |
| US7572807B2 (en) | 2005-06-09 | 2009-08-11 | Bristol-Myers Squibb Company | Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors |
| US7579360B2 (en) | 2005-06-09 | 2009-08-25 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| KR20080021085A (ko) | 2005-06-09 | 2008-03-06 | 유씨비 파마, 에스.에이. | 2，6 퀴놀리닐 유도체, 이들을 제조하는 방법 및 이들의약제로서의 용도 |
| US8119658B2 (en) | 2007-10-01 | 2012-02-21 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
| RU2684779C2 (ru) * | 2016-02-05 | 2019-04-15 | АО "Институт химических наук им. А.Б. Бектурова" | Применение производного бета-морфолинопропиоамидоксима в качестве противодиабетического средства |
| CN110092774B (zh) * | 2018-01-29 | 2022-04-08 | 中国科学院上海药物研究所 | 芳香丙酸类衍生物、及其制备方法和用途 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK173350B1 (da) | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
| GB9027023D0 (en) | 1990-12-12 | 1991-01-30 | Wellcome Found | Anti-atherosclerotic aryl compounds |
| GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
| BR9508468A (pt) * | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Composto processo para a preparação do mesmo composição farmacéutica processos para o tratamento e/ou profilaxia de hiperglicemia em um mamifero humano ou não humano e para o tratamento de hiperlípidemia hipertensão doença cardiovascular alguns distúrbios de alimentação o tratamento e/ou profilaxia de doença renal a prevenção revers o estabilização ou retardo da progressão de microalbuminuria em um mamifero humano ou não humano uso do composto e composto intermediário |
| JPH0912575A (ja) * | 1995-06-28 | 1997-01-14 | Sankyo Co Ltd | ベンゾオキサジンおよびベンゾチアジン誘導体 |
| GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
| AU1856997A (en) | 1996-02-02 | 1997-08-22 | Merck & Co., Inc. | Method for raising hdl cholesterol levels |
| GB9604242D0 (en) | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| GB9606805D0 (en) * | 1996-03-30 | 1996-06-05 | Glaxo Wellcome Inc | Medicaments |
| WO1998002159A1 (en) | 1996-07-12 | 1998-01-22 | Smithkline Beecham Plc | Novel treatment of leptine resistance |
| WO1999020614A1 (en) | 1998-05-27 | 1999-04-29 | Dr. Reddy's Research Foundation | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| RU2247722C2 (ru) * | 1997-10-27 | 2005-03-10 | Др. Редди`З Лабораториз Лимитед | Производные арилкарбоновых кислот, способы их получения, фармацевтическая композиция на их основе, способы лечения и предупреждения различных заболеваний, промежуточные соединения и способы их получения |
| US6265401B1 (en) * | 1997-10-27 | 2001-07-24 | Reddy-Cheminor, Inc. | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
-
2000
- 2000-04-25 JP JP2000615602A patent/JP2002543194A/ja not_active Withdrawn
- 2000-04-25 EP EP00919081A patent/EP1175412A1/en not_active Withdrawn
- 2000-04-25 NZ NZ515284A patent/NZ515284A/xx unknown
- 2000-04-25 YU YU75101A patent/YU75101A/sh unknown
- 2000-04-25 TR TR2001/03848T patent/TR200103848T2/xx unknown
- 2000-04-25 KR KR1020017013604A patent/KR100610578B1/ko not_active IP Right Cessation
- 2000-04-25 WO PCT/IB2000/000501 patent/WO2000066572A1/en not_active Application Discontinuation
- 2000-04-25 AU AU39831/00A patent/AU781079B2/en not_active Ceased
- 2000-04-25 HU HU0600105A patent/HUP0600105A3/hu unknown
- 2000-04-25 CZ CZ20013832A patent/CZ20013832A3/cs unknown
- 2000-04-25 RU RU2001132085/04A patent/RU2278114C2/ru not_active IP Right Cessation
- 2000-04-25 SK SK1509-2001A patent/SK15092001A3/sk unknown
- 2000-04-25 IL IL14610400A patent/IL146104A0/xx unknown
- 2000-04-25 PL PL00351987A patent/PL351987A1/xx not_active Application Discontinuation
- 2000-04-25 MX MXPA01010916A patent/MXPA01010916A/es active IP Right Grant
- 2000-04-25 CA CA002371757A patent/CA2371757A1/en not_active Abandoned
- 2000-04-25 US US09/959,093 patent/US7348426B1/en not_active Expired - Fee Related
- 2000-04-25 EE EEP200100540A patent/EE200100540A/xx unknown
- 2000-04-25 CN CN00808424A patent/CN1353699A/zh active Pending
- 2000-04-25 UA UA2001118039A patent/UA73501C2/uk unknown
- 2000-04-25 BR BR0010139-7A patent/BR0010139A/pt not_active IP Right Cessation
-
2001
- 2001-10-23 ZA ZA200108733A patent/ZA200108733B/en unknown
- 2001-10-24 HR HR20010785A patent/HRP20010785A2/hr not_active Application Discontinuation
- 2001-10-26 NO NO20015259A patent/NO320805B1/no unknown
- 2001-11-26 BG BG106146A patent/BG106146A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1175412A1 (en) | 2002-01-30 |
| KR100610578B1 (ko) | 2006-08-09 |
| NO20015259L (no) | 2001-11-15 |
| TR200103848T2 (tr) | 2002-04-22 |
| CZ20013832A3 (cs) | 2002-04-17 |
| NO20015259D0 (no) | 2001-10-26 |
| AU3983100A (en) | 2000-11-17 |
| CA2371757A1 (en) | 2000-11-09 |
| BG106146A (bg) | 2002-05-31 |
| RU2278114C2 (ru) | 2006-06-20 |
| HUP0600105A3 (en) | 2006-11-28 |
| JP2002543194A (ja) | 2002-12-17 |
| HUP0600105A2 (en) | 2006-05-29 |
| IL146104A0 (en) | 2002-07-25 |
| KR20010113891A (ko) | 2001-12-28 |
| US7348426B1 (en) | 2008-03-25 |
| MXPA01010916A (es) | 2002-06-21 |
| AU781079B2 (en) | 2005-05-05 |
| UA73501C2 (en) | 2005-08-15 |
| EE200100540A (et) | 2002-12-16 |
| NZ515284A (en) | 2004-12-24 |
| PL351987A1 (en) | 2003-07-14 |
| YU75101A (sh) | 2005-07-19 |
| SK15092001A3 (sk) | 2002-05-09 |
| NO320805B1 (no) | 2006-01-30 |
| CN1353699A (zh) | 2002-06-12 |
| BR0010139A (pt) | 2004-03-02 |
| HRP20010785A2 (en) | 2003-02-28 |
| WO2000066572A1 (en) | 2000-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200108733B (en) | Substituted bicyclic herocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents. | |
| ZA200106994B (en) | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical composition containing them. | |
| US6664411B2 (en) | Heterocyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them | |
| ZA200402910B (en) | Benzoxazine and benzothiazine drivatives and pharmaceutical compositions containing them. | |
| EP1051403A1 (en) | Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| JP2002507543A (ja) | 二環系化合物、その製造方法およびそれらを含有する薬学的組成物 | |
| WO2002081454A1 (en) | Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| US20060089500A1 (en) | New monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them | |
| US20030013729A1 (en) | New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them | |
| US6265401B1 (en) | Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them | |
| CA2307068C (en) | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| US20020169175A1 (en) | Pharmaceutically acceptable salts of heterocyclic compounds | |
| US20020169146A1 (en) | Pharmaceutically acceptable salts of tricyclic compounds | |
| CA2436738A1 (en) | Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose | |
| WO2002030914A1 (en) | Salts of benzothiazine and benzoxazine derivatives and pharmaceutical compositions containing them | |
| AU2006225184A1 (en) | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| US20020142993A1 (en) | Pharmaceutically acceptable salts of bicyclic compounds | |
| AU2002341289A1 (en) | Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them | |
| MXPA00004032A (en) | Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
| KR20060040757A (ko) | 치환된 이원 헤테로고리, 비만증 및 고콜레스테롤증치료제로서의 그 용도 | |
| NZ532284A (en) | Benzoxazine and Benzothiazine derivatives and parmaceutical compositions containing them |